Evidence map›Paper›PMID 38587201›Full record

ArticleNucleic acids research2024

MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation.

Zhiqiang Pang, Yao Lu, Guangyan Zhou, Fiona Hui, Lei Xu, Charles Viau, Aliya F Spigelman, Patrick E MacDonald, David S Wishart, Shuzhao Li and 1 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1,244 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,244citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07169123 recruitingnot on this mapstarted 2025, after this paper: background citation

Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD

TypeobservationalSponsorMcMaster UniversityRan2025 to 2029Enrolled300ConditionsCrohns Disease
NCT07512557 narecruitingnot on this mapstarted 2025, after this paper: background citation

Evaluating the Effectiveness and Feasibility of a Probiotic Intervention to Improve Nutrient Levels in Reproductive-Aged Women: A Pilot Study

TypeinterventionalSponsorCarleton UniversityRan2025 to 2026Enrolled82ConditionsProbiotic InterventionArmsProbiotic Capsule
3 · Its place in the literature

Who cites it

1,244 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Gut microbes · 2026
    Article
  5. Gut microbes · 2026
    Article
  6. Article
  7. Gut microbes · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Discovery of functional compounds from dimorphic edibleSynthetic and systems biotechnology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

1,184 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhiqiang PangInstitute of Parasitology, McGill University,Sainte-Anne-de-Bellevue, Quebec, Canada.
Yao LuDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Guangyan ZhouInstitute of Parasitology, McGill University,Sainte-Anne-de-Bellevue, Quebec, Canada.
Fiona HuiInstitute of Parasitology, McGill University,Sainte-Anne-de-Bellevue, Quebec, Canada.
Lei XuInstitute of Parasitology, McGill University,Sainte-Anne-de-Bellevue, Quebec, Canada.
Charles ViauInstitute of Parasitology, McGill University,Sainte-Anne-de-Bellevue, Quebec, Canada.
Aliya F SpigelmanDepartment of Pharmacology and Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.
Patrick E MacDonaldDepartment of Pharmacology and Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.
David S WishartDepartments of Biological Sciences and Computing Science, University of Alberta, Edmonton, Alberta, Canada.
Shuzhao LiThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Jianguo XiaInstitute of Parasitology, McGill University,Sainte-Anne-de-Bellevue, Quebec, Canada.ORCID 0000-0003-2040-2624

Funding

Mummichog 3, aligning mass spectrometry data to biological networks - Neutral LossU01CA235493 · NCI · JACKSON LABORATORY · PI LI, SHUZHAO, SIUZDAK, GARY E · 2018 to 2021
$2.0M
CFICIHRDiabetes CanadaGenome CanadaJuvenile Diabetes Research FoundationNatural Sciences and Engineering Research Council of CanadaNCI NIH HHS U01 CA235493
6 · The paper itself

Abstract

We introduce MetaboAnalyst version 6.0 as a unified platform for processing, analyzing, and interpreting data from targeted as well as untargeted metabolomics studies using liquid chromatography - mass spectrometry (LC-MS). The two main objectives in developing version 6.0 are to support tandem MS (MS2) data processing and annotation, as well as to support the analysis of data from exposomics studies and related experiments. Key features of MetaboAnalyst 6.0 include: (i) a significantly enhanced Spectra Processing module with support for MS2 data and the asari algorithm; (ii) a MS2 Peak Annotation module based on comprehensive MS2 reference databases with fragment-level annotation; (iii) a new Statistical Analysis module dedicated for handling complex study design with multiple factors or phenotypic descriptors; (iv) a Causal Analysis module for estimating metabolite - phenotype causal relations based on two-sample Mendelian randomization, and (v) a Dose-Response Analysis module for benchmark dose calculations. In addition, we have also improved MetaboAnalyst's visualization functions, updated its compound database and metabolite sets, and significantly expanded its pathway analysis support to around 130 species. MetaboAnalyst 6.0 is freely available at https://www.metaboanalyst.ca.

Indexed as

AlgorithmsMetabolomicsSoftwareTandem Mass SpectrometryChromatography, LiquidDatabases, FactualHumans

Identifiers

PMID38587201
PMCPMC11223798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.